DIRECTOR DEALINGS SUMMARY: TalkTalk Executive Chair Spends GBP400,000
DIRECTOR DEALINGS SUMMARY: TalkTalk Executive Chair Spends GBP400,000
Read moreDIRECTOR DEALINGS SUMMARY: TalkTalk Executive Chair Spends GBP400,000
Read moreUK BROKER RATINGS SUMMARY: Investec Raises RBS To Buy From Hold
Read more(Sharecast News) - Indivior warned it would suffer a loss this year after collapsing sales of its controversial Suboxone opioid-addiction treatment caused profit to fall more than a third in 2019.
Read moreUK WINNERS & LOSERS SUMMARY: Centrica Plunges After Swinging To Loss
Read moreIndivior Sinks As It Warns Of 2020 Loss And Potential Legal Costs
Read moreIndivior And Virginia Tech To Collaborate On Recover Study Extension
Read moreIndivior Reports Positive Results From Sublocade Injection Analysis
Read moreIndivior In Campaign To Ramp Up Opioid-Addiction Drug Awareness
Read moreIndivior Third Quarter Profit Drops On Generic Competition In US
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read moreIndivior Hires Ex-Shire Numbers Boss Hetherington As Non-Executive
Read moreLONDON MARKET MIDDAY: FTSE Suffers As Pound Gains On Brexit Deal Hopes
Read moreUK WINNERS & LOSERS SUMMARY: Vesuvius Shares Melt After Profit Warning
Read moreIndivior Boosts 2019 Earnings Guidance Again As Opioid Drug Sales Rise
Read more(Sharecast News) - Indivior shares rallied on Tuesday after the pharmaceuticals company lifted its revenue outlook again following a stronger-than-expected performance from its opioid-addiction treatment Suboxone.
Read more